Slow Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Slow Capital’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-162	Closed	-$10K	–	180
2020 Q3	$10K	Buy	+162	New	+$9.49K	﹤0.01%	228

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

MCM

Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return

CAN

Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return

Slow Capital's ARKG Position: Q4 2020 in Review

Slow Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2020, closing a stake of 162 shares — an estimated $10K sold.

Slow Capital first reported a position in ARKG in Q3 2020 and held it in 1 quarter. The position peaked at $10K in Q3 2020. 414 funds tracked by Wall St. Rank hold ARKG as of Q4 2020.

Slow Capital reported no remaining ARK Genomic Revolution ETF position as of Q4 2020 after selling out during the quarter.
Slow Capital sold 162 ARK Genomic Revolution ETF shares in Q4 2020, an estimated $10K.
Slow Capital first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 1 quarter.
Slow Capital's ARK Genomic Revolution ETF position peaked at $10K in Q3 2020.
414 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2020.

Based on Slow Capital's 13F filing for Q4 2020, filed 11 Feb 2021.